In 2017, Delaware courts issued decisions that have fundamentally altered corporate governance litigation. We discuss the most significant judicial and regulatory developments in our year-end review.
Plaintiffs filed 226 new federal class actions in the first half of 2017, more than double the average rate over the last 20 years, and an additional 99 federal class actions in the third quarter.
Cadwalader Represents New Mexico Health Connections in Sale of Group Health Business to Evolent Health
The Cadwalader team includes Stephanie Marcantonio, Bill Mills, Paul Mourning, Peter Bariso, Michael DiFiore, Gianna Sagan, David Teigman, Linda Swartz, Jean Bertrand, Dorothy Auth and Michael Sebba.
Cadwalader Advises The Howard Hughes Corporation in Connection with Underwritten Public Secondary Offering
The Cadwalader team is led by Richard Brand, Braden McCurrach and Matthew Sadofsky, and includes Mattan Erder, Victoria Saunders and Edward Wei.
The firm is representing the Bermuda-based specialty provider of property and casualty insurance and reinsurance in its agreement to purchase the operating subsidiaries of Lexon Surety Group LLC.
The firm was named the 2018 "Finance Firm of the Year” for Securitization by The Legal 500 UK.
"These are outstanding lawyers with an unwavering commitment to client service and demonstrated excellence,” said Pat Quinn, Cadwalader’s Managing Partner.
Cadwalader is representing The Medicines Company in its agreement to sell its infectious disease business unit to Melinta Therapeutics, Inc.